Dizal (Jiangsu) Pharmaceutical Co., Ltd. Stock
Equities
688192
CNE1000055W8
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
45.05 CNY | -0.29% | +1.49% | -5.85% |
Sales 2023 | 91.29M 12.61M | Sales 2024 * | 430M 59.4M | Capitalization | 18.73B 2.59B |
---|---|---|---|---|---|
Net income 2023 | -1.11B -153M | Net income 2024 * | -649M -89.65M | EV / Sales 2023 | 214 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 43.5 x |
P/E ratio 2023 |
-17.6
x | P/E ratio 2024 * |
-28.9
x | Employees | 424 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 18.48% |
1 day | -0.29% | ||
1 week | +1.49% | ||
1 month | +7.34% | ||
3 months | +46.89% | ||
6 months | +4.55% | ||
Current year | -5.85% |
Managers | Title | Age | Since |
---|---|---|---|
Xiao Lin Zhang
CEO | Chief Executive Officer | 60 | 17-10-26 |
Wei Wen Dong
CHM | Chairman | 38 | 18-05-31 |
Hong Bin Lu
DFI | Director of Finance/CFO | 46 | 20-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Lü
BRD | Director/Board Member | 56 | 17-09-30 |
Xue Gong Wang
BRD | Director/Board Member | 52 | 20-09-06 |
Guan Shan Zhu
BRD | Director/Board Member | 60 | 20-09-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 45.05 | -0.29% | 1,758,359 |
24-04-29 | 45.18 | +1.78% | 2,392,158 |
24-04-26 | 44.39 | +3.26% | 2,087,549 |
24-04-25 | 42.99 | +1.92% | 2,988,799 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.85% | 2.59B | |
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |
- Stock Market
- Equities
- 688192 Stock